Reata Pharmaceuticals (Reata) and Kyowa Hakko Kirin have entered into a licensing agreement that provides the latter with the exclusive rights to develop and commercialise Reata’s lead compound,
William Miller, CEO of AIBioTech, said: “The automation provided by AutoGenomics’ INFINITI Analyzer has enhanced workflow in our laboratories. With their expanding menu of molecular applications we have
Cell Medica has entered into an R&D agreement with the Center for Cell and Gene Therapy (Center), a joint program of Baylor College of Medicine. The agreement forms
BASF has named Stefan Beckmann as the head of the Care Chemicals and Formulators Europe unit. Dr. Beckmann has taken charge on January 1, 2010. He succeeds Friedrich
The FDA has granted Orphan Drug Designation to Biovest International (Biovest) for its personalised lymphoma vaccine, BiovaxID. The company claims that BiovaxID represents a new class of active
Hi-Tech Pharmacal (Hi-Tech) has received clearance from the FDA to market Tropazone lotion, a prescription dermatological product which is expected to be promoted by Hi-Tech’s branded marketing subsidiary,
The collaboration aims to improve diagnosis and management of disease in critical care settings within hospitals, such as emergency departments, coronary units and ICUs. The new alliance unites
Robinson Pharma (RPI) has joined the Council for Responsible Nutrition (CRN) as a full voting member. Robinson is expected to contribute to the overall health and success of
When approved for use with venous whole blood, the OraQuick HCV test is expected to be the first rapid HCV test approved by the FDA for use in
Hari Kumar, chief business officer of Amira Pharmaceuticals, said: “Achieving this milestone further demonstrates the success of our partnership with GSK and provides a meaningful economic benefit to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.